Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma

Review

(3260) Views  (1092) Full article downloads

Authors: Timothy J Schaffner, David P Skoner

Published Date February 2009 Volume 2009:2 Pages 25 - 32

DOI: http://dx.doi.org/10.2147/JAA.S4651

Timothy J Schaffner^1,2

David P Skoner^1,2,3

¹Division of Allergy, Asthma, and Immunology, Allegheny General Hospital, Pittsburgh, PA, USA; ²West Virginia University School of Medicine, Morgantown, WV, USA; ³Drexel College of Medicine, Philadelphia, PA, USA

Abstract: Ciclesonide is a novel inhaled corticosteroid used in the continuous treatment of mild-to-severe asthma. Its formulation and mechanism of action yield a low oral and systemic bioavailability, and high pulmonary deposition. In multiple clinical trials, ciclesonide is at least as effective as either fluticasone propionate or budesonide at symptom control, while in many cases having improved safety outcomes and tolerability. The improved safety and comparable efficacy profiles of ciclesonide demonstrated in current studies could potentially yield a treatment option that may lead to improved adherence and outcome.

Keywords: ciclesonide, asthma, inhaled corticosteroid